Micardis® in Patients With Essential Hypertension

Boehringer Ingelheim1,688 enrolled

Overview

The aim of this observational study was to supplement the data on efficacy, safety, and tolerability of telmisartan under daily conditions in hospitals

Study Type

OBSERVATIONAL

Enrollment

1,688

Conditions

Hypertension

Interventions

Telmisartan tabletsDRUG

All patients were treated with different doses of telmisartan for 14 days

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with essential hypertension * Minimum age of 18 years Exclusion Criteria: Not applicable

Outcomes

Primary Outcomes

Changes from baseline in blood pressure

Evaluation was performed separately for three patient groups depending on their hypertension status at baseline (normotension, essential hypertension and isolated hypertension)

Time frame: Up to 14 days

Number of patients with adverse events

Time frame: Up to 14 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.